Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011 Nov;118(5):1157-1163.
doi: 10.1097/AOG.0b013e31823403f4.

Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification

Luis D Pacheco  1 , Richard L Berkowitz, Kenneth J Moise Jr, James B Bussel, Janice G McFarland, George R Saade
Affiliations

Fetal and neonatal alloimmune thrombocytopenia: a management algorithm based on risk stratification

Luis D Pacheco et al. Obstet Gynecol. 2011 Nov.

Abstract

Fetal and neonatal alloimmune thrombocytopenia constitutes the most common cause of severe thrombocytopenia in fetuses and neonates and of intracranial hemorrhage among term newborns. The cornerstone of therapy involves the use of steroids and intravenous immunoglobulins. Despite the risk of potentially devastating consequences to the fetus, fetal blood sampling has typically been used to document response to therapy. We propose a therapeutic algorithm based on risk stratification with individualized treatment optimization without the use of fetal blood sampling.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

    1. Hohlfeld P, Forestier F, Kaplan C, Tissot JD, Daffos F. Fetal thrombocytopenia: a retrospective study of 5,194 fetal blood samplings. Blood 1994;84:1851–6.
    1. Bussel JB, Zabusky ME, Berkowitz RL, McFarland JG. Fetal alloimmune thrombocytopenia. N Engl J Med 1997;337:22–6.
    1. Mao C, Guo J, Chituwo BM. Intraventricular hemorrhage and it's prognosis, prevention, and treatment in term infants. J Trop Pediatr.1999;45:237–40.
    1. Bussel JB, Zacharoulis S, Kramer K, McFarland JG, Pauliny J, Kaplan C. Clinical and diagnostic comparison of neonatal alloimmune thrombocytopenia to non-immune cases of thrombocytopenia. Pediatr Blood Cancer 2005;45:176–83.
    1. Turner M, Bessos H, Fagge T, Harkness M, Rentoul F, Seymour J, et al.. Prospective epidemiologic study of the outcome and cost-effectiveness of antenatal screening to detect neonatal alloimmune thrombocytopenia due to anti-HPA-1a. Transfusion 2005;45:1945–56.

LinkOut - more resources